Fuad El Rassi, MD
Dr. Fuad El Rassi, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board-certified hematologist, Dr. El Rassi treats patients with sickle cell anemia and other blood disorders. He leads the sickle cell research program at Grady Health System. Dr. El Rassi is involved in hematology and medical oncology fellows’ training and education in benign hematology and chairs the Fellowship Competency Committee.
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: ECFMG - Educational Commission For Foreign Medical Graduates
- Residency: American University of Beirut Medical Center
Fellowships
Emory University School of Medicine
Locations and Directions
Correll Pavilion
Monday - Friday: 6 a.m. - 5:30 p.m.
Saturday: 7:30 a.m. - 3:30 p.m.
Grady Memorial Hospital
OPEN 24 HOURS
Visiting hours are from 8 a.m. – 10:30 p.m. daily
Publications
- A prospective study of high-impact chronic pain in sickle cell disease: the Sickle Pain-Related Impact (SPiRIt) study.
Jagtiani A, Hawk A, Sinha C, Gillespie SE, Mirbeyk M, Burke R, Ifendu N, Reese S, Howard V, Boguslawski S, Thompson O, Ikkurthy N, El Rassi F, Smith WR, Krishnamurti L, Sil S, Bakshi N
Pain. 2026;167(7):1578-1592.
PMID: 42017907 - The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future.
El Rassi F, Andemariam B, Kutlar A, Pace BS, Fink A, Torres K, Dowd C, Abrams CS
Blood advances. 2026;10(1):48-57.
PMID: 40902083 - The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center.
Afranie-Sakyi JA, Randall E, Fasano R, McLemore ML, El Rassi F
European journal of haematology. 2025;114(4):663-671.
PMID: 39748504 - Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier C, Jaroscak JJ, Bergmann S, Wong T, Kota V, Pace B, Lekakis LJ, Lulla P, Nickel RS, Kasow KA, Popat U, Smith W, Yu L, DiFronzo N, Geller N, Kamani N, Klings ES, Hassell K, Mendizabal A, Sullivan K, Neuberg D, Krishnamurti L
Blood advances. 2025;9(5):955-965.
PMID: 39471440 - Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
Arnold SD, Bakshi N, Ross D, Smith C, Sinha C, Veludhandi A, Dutreuil V, Bai S, Meacham LR, Guilcher G, Bhatia M, Abraham A, Kasow KA, Haight A, El Rassi F, Stenger E, Lipscomb J, Krishnamurti L
American journal of hematology. 2024;99(10):2037-2040.
PMID: 39105410 - Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
Gladwin MT, Gordeuk VR, Desai PC, Minniti C, Novelli EM, Morris CR, Ataga KI, De Castro L, Curtis SA, El Rassi F, Ford HJ, Harrington T, Klings ES, Lanzkron S, Liles D, Little J, Nero A, Smith W, Taylor JG, Baptiste A, Hagar W, Kanter J, Kinzie A, Martin T, Rafique A, Telen MJ, Lalama CM, Kato GJ, Abebe KZ
The Lancet. Haematology. 2024;11(5):e345-e357.
PMID: 38554715 - Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
Nakahara H, Cheedarla N, Verkerke HP, Cheedarla S, Wu SC, Hendrickson JE, Chang A, McLemore ML, El Rassi F, Roback JD, Neish AS, Fasano RM, Stowell SR
British journal of haematology. 2023;202(5):937-941.
PMID: 37287128 - Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system.
Clarke K, Shin YM, Hall MAK, Moussa M, McLemore M, El Rassi F
Expert review of hematology. 2023;16(2):151-156.
PMID: 36562409 - A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Dampier CD, Telen MJ, Wun T, Brown RC, Desai P, El Rassi F, Fuh B, Kanter J, Pastore Y, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray H, Magnani JL, Hassell KL,
Blood. 2023;141(2):168-179.
PMID: 35981565 - Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.
Clarke K, Benameur K, Wiley Z, Shin YM, Moussa M, El Rassi F, McLemore M
Journal of investigative medicine high impact case reports. 2022;
PMID: 35850596
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.